Clinical Trial Update: Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications [NA]

View source ↗

Summary

A completed clinical trial evaluating surgery, intravitreal tissue plasminogen activator, and antiangiogenic therapy for subretinal haemorrhage in age-related m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Antiangiogenic agents (intravitreal)
• Tissue Plasminogen Activator (Alteplase) (Alteplase)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Subretinal Haematoma Linked to AMD | NA | Status: COMPLETED